A proteasome inhibitor prevents activation of NF‐kappa B and stabilizes a newly phosphorylated form of I kappa B‐alpha that is still bound to NF‐kappa B.

E. Britta-Mareen Traenckner(University of Freiburg), Patrick A. Baeuerle(C4 Therapeutics (United States))
The EMBO Journal
November 1, 1994
10.1002/j.1460-2075.1994.tb06878.x
Cited by 716

Related Papers

H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor.
|The EMBO Journal|1993|1.3k
Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli.
|The EMBO Journal|1995|1k